<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Prescient Therapeutics Limited — News on 6ix</title>
    <link>https://6ix.com/company/prescient-therapeutics-ltd</link>
    <description>Latest news and press releases for Prescient Therapeutics Limited on 6ix.</description>
    <language>en-us</language>
    <lastBuildDate>Thu, 30 Apr 2026 03:45:14 GMT</lastBuildDate>
    <generator>6ix RSS</generator>
    <atom:link href="https://6ix.com/rss/company/prescient-therapeutics-ltd" rel="self" type="application/rss+xml" />
    <image>
      <url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo683667e878dffbe2df15e84a.webp</url>
      <title>Prescient Therapeutics Limited</title>
      <link>https://6ix.com/company/prescient-therapeutics-ltd</link>
    </image>
    <item>
      <title>March 2026 Quarterly Update and Appendix 4C</title>
      <link>https://6ix.com/company/prescient-therapeutics-ltd/news/march-2026-quarterly-update-and-appendix-4c-1</link>
      <guid isPermaLink="true">https://6ix.com/company/prescient-therapeutics-ltd/news/march-2026-quarterly-update-and-appendix-4c-1</guid>
      <pubDate>Thu, 30 Apr 2026 03:45:14 GMT</pubDate>
      <description>March 2026 Quarterly Update and Appendix 4C</description>
    </item>
    <item>
      <title>Appendix 4D and Half Year Financial Report</title>
      <link>https://6ix.com/company/prescient-therapeutics-ltd/news/appendix-4d-and-half-year-financial-report-78</link>
      <guid isPermaLink="true">https://6ix.com/company/prescient-therapeutics-ltd/news/appendix-4d-and-half-year-financial-report-78</guid>
      <pubDate>Tue, 24 Feb 2026 11:20:08 GMT</pubDate>
      <description>Appendix 4D and Half Year Financial Report</description>
    </item>
    <item>
      <title>December 2025 Quarterly Update and Appendix 4C</title>
      <link>https://6ix.com/company/prescient-therapeutics-ltd/news/december-2025-quarterly-update-and-appendix-4c-1</link>
      <guid isPermaLink="true">https://6ix.com/company/prescient-therapeutics-ltd/news/december-2025-quarterly-update-and-appendix-4c-1</guid>
      <pubDate>Fri, 30 Jan 2026 03:37:09 GMT</pubDate>
      <description>December 2025 Quarterly Update and Appendix 4C</description>
    </item>
    <item>
      <title>PTX secures EU Authorisation to commence PTX-100 Trial</title>
      <link>https://6ix.com/company/prescient-therapeutics-ltd/news/ptx-secures-eu-authorisation-to-commence-ptx-100-trial</link>
      <guid isPermaLink="true">https://6ix.com/company/prescient-therapeutics-ltd/news/ptx-secures-eu-authorisation-to-commence-ptx-100-trial</guid>
      <pubDate>Mon, 15 Dec 2025 03:31:07 GMT</pubDate>
      <description>PTX secures EU Authorisation to commence PTX-100 Trial</description>
    </item>
    <item>
      <title>PTX secures EU Orphan Drug Designation for PTX-100 in CTCL</title>
      <link>https://6ix.com/company/prescient-therapeutics-ltd/news/ptx-secures-eu-orphan-drug-designation-for-ptx-100-in-ctcl</link>
      <guid isPermaLink="true">https://6ix.com/company/prescient-therapeutics-ltd/news/ptx-secures-eu-orphan-drug-designation-for-ptx-100-in-ctcl</guid>
      <pubDate>Wed, 19 Nov 2025 03:23:17 GMT</pubDate>
      <description>PTX secures EU Orphan Drug Designation for PTX-100 in CTCL</description>
    </item>
    <item>
      <title>September Quarterly Updated and Appendix 4C</title>
      <link>https://6ix.com/company/prescient-therapeutics-ltd/news/september-quarterly-updated-and-appendix-4c</link>
      <guid isPermaLink="true">https://6ix.com/company/prescient-therapeutics-ltd/news/september-quarterly-updated-and-appendix-4c</guid>
      <pubDate>Fri, 10 Oct 2025 02:28:23 GMT</pubDate>
      <description>September Quarterly Updated and Appendix 4C</description>
    </item>
    <item>
      <title>Appendix 4E and 2025 Annual Report</title>
      <link>https://6ix.com/company/prescient-therapeutics-ltd/news/appendix-4e-and-2025-annual-report-36</link>
      <guid isPermaLink="true">https://6ix.com/company/prescient-therapeutics-ltd/news/appendix-4e-and-2025-annual-report-36</guid>
      <pubDate>Wed, 20 Aug 2025 10:49:17 GMT</pubDate>
      <description>Appendix 4E and 2025 Annual Report</description>
    </item>
    <item>
      <title>Prescient successfully completes $3 million Placement</title>
      <link>https://6ix.com/company/prescient-therapeutics-ltd/news/prescient-successfully-completes-dollar3-million-placement</link>
      <guid isPermaLink="true">https://6ix.com/company/prescient-therapeutics-ltd/news/prescient-successfully-completes-dollar3-million-placement</guid>
      <pubDate>Thu, 31 Jul 2025 04:45:14 GMT</pubDate>
      <description>Prescient successfully completes $3 million Placement</description>
    </item>
    <item>
      <title>June 2025 Quarterly Update and Appendix 4C</title>
      <link>https://6ix.com/company/prescient-therapeutics-ltd/news/june-2025-quarterly-update-and-appendix-4c-1</link>
      <guid isPermaLink="true">https://6ix.com/company/prescient-therapeutics-ltd/news/june-2025-quarterly-update-and-appendix-4c-1</guid>
      <pubDate>Wed, 30 Jul 2025 04:02:15 GMT</pubDate>
      <description>June 2025 Quarterly Update and Appendix 4C</description>
    </item>
    <item>
      <title>Prescient announces results of SPP &amp; Launches Placement</title>
      <link>https://6ix.com/company/prescient-therapeutics-ltd/news/prescient-announces-results-of-spp-and-launches-placement</link>
      <guid isPermaLink="true">https://6ix.com/company/prescient-therapeutics-ltd/news/prescient-announces-results-of-spp-and-launches-placement</guid>
      <pubDate>Tue, 29 Jul 2025 04:15:10 GMT</pubDate>
      <description>Prescient announces results of SPP &amp; Launches Placement</description>
    </item>
    <item>
      <title>Trading Halt</title>
      <link>https://6ix.com/company/prescient-therapeutics-ltd/news/trading-halt-707</link>
      <guid isPermaLink="true">https://6ix.com/company/prescient-therapeutics-ltd/news/trading-halt-707</guid>
      <pubDate>Tue, 29 Jul 2025 03:37:20 GMT</pubDate>
      <description>Trading Halt</description>
    </item>
    <item>
      <title>Prescient Therapeutics - Extension of Share Purchase Plan</title>
      <link>https://6ix.com/company/prescient-therapeutics-ltd/news/prescient-therapeutics-extension-of-share-purchase-plan</link>
      <guid isPermaLink="true">https://6ix.com/company/prescient-therapeutics-ltd/news/prescient-therapeutics-extension-of-share-purchase-plan</guid>
      <pubDate>Tue, 22 Jul 2025 04:05:09 GMT</pubDate>
      <description>Prescient Therapeutics - Extension of Share Purchase Plan</description>
    </item>
    <item>
      <title>PTX Opens First U.S. Site for PTX-100 Phase 2a Trial</title>
      <link>https://6ix.com/company/prescient-therapeutics-ltd/news/ptx-opens-first-us-site-for-ptx-100-phase-2a-trial</link>
      <guid isPermaLink="true">https://6ix.com/company/prescient-therapeutics-ltd/news/ptx-opens-first-us-site-for-ptx-100-phase-2a-trial</guid>
      <pubDate>Wed, 16 Jul 2025 03:29:13 GMT</pubDate>
      <description>PTX Opens First U.S. Site for PTX-100 Phase 2a Trial</description>
    </item>
    <item>
      <title>Prescient Therapeutics Extends Share Purchase Plan</title>
      <link>https://6ix.com/company/prescient-therapeutics-ltd/news/prescient-therapeutics-extends-share-purchase-plan</link>
      <guid isPermaLink="true">https://6ix.com/company/prescient-therapeutics-ltd/news/prescient-therapeutics-extends-share-purchase-plan</guid>
      <pubDate>Tue, 15 Jul 2025 03:39:14 GMT</pubDate>
      <description>Prescient Therapeutics Extends Share Purchase Plan</description>
    </item>
    <item>
      <title>Prescient Therapeutics Opens Share Purchase Plan</title>
      <link>https://6ix.com/company/prescient-therapeutics-ltd/news/prescient-therapeutics-opens-share-purchase-plan</link>
      <guid isPermaLink="true">https://6ix.com/company/prescient-therapeutics-ltd/news/prescient-therapeutics-opens-share-purchase-plan</guid>
      <pubDate>Wed, 02 Jul 2025 03:42:17 GMT</pubDate>
      <description>Prescient Therapeutics Opens Share Purchase Plan</description>
    </item>
    <item>
      <title>Prescient Therapeutics Launches Share Purchase Plan for $7m</title>
      <link>https://6ix.com/company/prescient-therapeutics-ltd/news/prescient-therapeutics-launches-share-purchase-plan-for-dollar7m</link>
      <guid isPermaLink="true">https://6ix.com/company/prescient-therapeutics-ltd/news/prescient-therapeutics-launches-share-purchase-plan-for-dollar7m</guid>
      <pubDate>Tue, 01 Jul 2025 03:31:08 GMT</pubDate>
      <description>Prescient Therapeutics Launches Share Purchase Plan for $7m</description>
    </item>
    <item>
      <title>First Patient dosed for PTX-100 Phase 2a Study</title>
      <link>https://6ix.com/company/prescient-therapeutics-ltd/news/first-patient-dosed-for-ptx-100-phase-2a-study</link>
      <guid isPermaLink="true">https://6ix.com/company/prescient-therapeutics-ltd/news/first-patient-dosed-for-ptx-100-phase-2a-study</guid>
      <pubDate>Tue, 27 May 2025 03:28:17 GMT</pubDate>
      <description>First Patient dosed for PTX-100 Phase 2a Study</description>
    </item>
    <item>
      <title>March 2025 Quarterly Update and Appendix 4C</title>
      <link>https://6ix.com/company/prescient-therapeutics-ltd/news/march-2025-quarterly-update-and-appendix-4c-1</link>
      <guid isPermaLink="true">https://6ix.com/company/prescient-therapeutics-ltd/news/march-2025-quarterly-update-and-appendix-4c-1</guid>
      <pubDate>Mon, 28 Apr 2025 04:21:05 GMT</pubDate>
      <description>March 2025 Quarterly Update and Appendix 4C</description>
    </item>
    <item>
      <title>PTX-100 receives U.S. FDA Fast Track Designation</title>
      <link>https://6ix.com/company/prescient-therapeutics-ltd/news/ptx-100-receives-us-fda-fast-track-designation</link>
      <guid isPermaLink="true">https://6ix.com/company/prescient-therapeutics-ltd/news/ptx-100-receives-us-fda-fast-track-designation</guid>
      <pubDate>Wed, 16 Apr 2025 03:41:04 GMT</pubDate>
      <description>PTX-100 receives U.S. FDA Fast Track Designation</description>
    </item>
    <item>
      <title>PTX Opens First Clinical site for PTX-100 Phase 2a Study</title>
      <link>https://6ix.com/company/prescient-therapeutics-ltd/news/ptx-opens-first-clinical-site-for-ptx-100-phase-2a-study</link>
      <guid isPermaLink="true">https://6ix.com/company/prescient-therapeutics-ltd/news/ptx-opens-first-clinical-site-for-ptx-100-phase-2a-study</guid>
      <pubDate>Wed, 26 Mar 2025 02:14:14 GMT</pubDate>
      <description>PTX Opens First Clinical site for PTX-100 Phase 2a Study</description>
    </item>
  </channel>
</rss>